<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25581336</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2249</ISSN><JournalIssue CitedMedium="Internet"><Volume>180</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>May</Month></PubDate></JournalIssue><Title>Clinical and experimental immunology</Title><ISOAbbreviation>Clin Exp Immunol</ISOAbbreviation></Journal><ArticleTitle>Association of killer cell immunoglobulin-like receptor and human leucocyte antigen-Cw gene combinations with systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>250</StartPage><EndPage>254</EndPage><MedlinePgn>250-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cei.12582</ELocationID><Abstract><AbstractText>Killer cell immunoglobulin-like receptors (KIRs) are a diverse family of activating and inhibitory receptors expressed on natural killer (NK) cells and T cells, the genes of which show extreme polymorphism. Some KIRs bind to human leucocyte antigen (HLA) class I subgroups, and genetic interactions between KIR genes and their ligand HLA have been shown to be associated with several autoimmune diseases. The present study aimed to investigate whether the combinations of KIR genes and HLA-Cw ligands associate with the susceptibility of systemic lupus erythematosus (SLE). Polymerase chain reaction using sequence-specific primers was used to determine the genotypes of KIR genes and HLA-Cw alleles. We found that the frequencies of HLA-Cw07 were statistically significantly higher in the patient group than those in the control group (P&#x2009;=&#x2009;0&#xb7;009). KIR2DS1(+) HLA(-) Cw(Lys) was more common in subjects with SLE compared to control subjects (P&#x2009;=&#x2009;0&#xb7;015). In addition, the frequency of KIR2DS1 was increased in SLE when KIR2DL1/HLA-Cw are absent, and the difference was significant (P&#x2009;=&#x2009;0&#xb7;001). KIR genotype and HLA ligand interaction may potentially influence the threshold for NK (and/or T) cell activation mediated through activating receptors, thereby contributing to the pathogenesis of SLE.</AbstractText><CopyrightInformation>&#xa9; 2015 British Society for Immunology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Shandong Provincial Qianfoshan Hospital, Shandong University, Ji-nan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Exp Immunol</MedlineTA><NlmUniqueID>0057202</NlmUniqueID><ISSNLinking>0009-9104</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015236">HLA-C Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C040178">HLA-C*70 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C496212">KIR2DS1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054340">Receptors, KIR</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="Y">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="Y">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015236" MajorTopicYN="N">HLA-C Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054340" MajorTopicYN="N">Receptors, KIR</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">genes</Keyword><Keyword MajorTopicYN="N">killer cell immunoglobulin-like receptors</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25581336</ArticleId><ArticleId IdType="pmc">PMC4408160</ArticleId><ArticleId IdType="doi">10.1111/cei.12582</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wong M, Tsao BP. Current topics in human SLE genetics. Springer Semin Immunopathol. 2006;28:97&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">16941108</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyagawa H, Yamai M, Sakaguchi D, et al. Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology (Oxf) 2008;47:158&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">18174230</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama T, Tsukamoto H, Masumoto K, et al. A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus. Rheumatology (Oxf) 2003;42:980&#x2013;985.</Citation><ArticleIdList><ArticleId IdType="pubmed">12730512</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao K, Fujii M, Tsukumo S, et al. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis. 2007;66:905&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1955115</ArticleId><ArticleId IdType="pubmed">17344245</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiuchi T, Kiyohara C, Tsukamoto H, et al. A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case&#x2013;control study and a meta-analysis. Ann Rheum Dis. 2007;66:320&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1856025</ArticleId><ArticleId IdType="pubmed">17028114</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YW, Kee SJ, Cho YN, et al. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum. 2009;60:1753&#x2013;1763.</Citation><ArticleIdList><ArticleId IdType="pubmed">19479851</ArticleId></ArticleIdList></Reference><Reference><Citation>Hervier B, Beziat V, Haroche J, et al. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-&#x3b3; production in patients with active disease. Arthritis Rheum. 2011;63:1698&#x2013;1706.</Citation><ArticleIdList><ArticleId IdType="pubmed">21370226</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibson PJ. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity. 1997;6:655&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">9208838</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">15771571</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AP, Bateman AR, Khakoo SI. Hanging in the balance: KIR and their role in disease. Mol Interv. 2005;5:226&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">16123537</ArticleId></ArticleIdList></Reference><Reference><Citation>Moesta AK, Parham P. Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. Front Immunol. 2012;3:336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3504360</ArticleId><ArticleId IdType="pubmed">23189078</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajalingam R. Human diversity of killer cell immunoglobulin-like receptors and disease. Korean J Hematol. 2011;46:216&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3259513</ArticleId><ArticleId IdType="pubmed">22259627</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton D, Gonzelez F. The extensive polymorphism of KIR genes. Immunology. 2010;129:8&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2807482</ArticleId><ArticleId IdType="pubmed">20028428</ArticleId></ArticleIdList></Reference><Reference><Citation>Parham P, Norman PJ, Abi-Rached L, Guethlein LA. Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Phil Trans R Soc Lond B Biol Sci. 2012;367:800&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3267113</ArticleId><ArticleId IdType="pubmed">22312047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimoto Y, Horiuchi T, Tsukamoto H, et al. Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections. Rheumatology (Oxf) 2010;49:1346&#x2013;1353.</Citation><ArticleIdList><ArticleId IdType="pubmed">20371502</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedroza LS, Sauma MF, Vasconcelos JM, et al. Systemic lupus erythematosus: association with KIR and SLC11A1 polymorphisms, ethnic predisposition and influence in clinical manifestations at onset revealed by ancestry genetic markers in an urban Brazilian population. Lupus. 2011;20:265&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">21233146</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao YL, Zhang BC, You L, et al. Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis. J Clin Immunol. 2010;30:840&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-De los Santos S, S&#xe1;nchez-Hern&#xe1;ndez PE, Mu&#xf1;oz-Valle JF, et al. Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis. Dis Markers. 2012;33:201&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3810684</ArticleId><ArticleId IdType="pubmed">22960345</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou YF, Zhang YC, Jiao YL, et al. Disparate distribution of activating and inhibitory killer cell immunoglobulinlike receptor genes in patients with systemic lupus erythematosus. Lupus. 2010;19:20&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">19926642</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin MP, Nelson G, Lee JH, et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol. 2002;169:2818&#x2013;2822.</Citation><ArticleIdList><ArticleId IdType="pubmed">12218090</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 &amp; DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP) Tissue Antigens. 1995;46:355&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">8838344</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu XZ, Hong KX, Qin GM, et al. Genotyping of HLA-Cw locus in Chinese Yi ethnic group by PCR&#x2013;SSP. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2003;17:62&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">12870022</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran V, Bull SB, Pellett FJ, Ayearst R, Pollock RA, Gladman DD. Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis. Rheumatology (Oxf) 2014;53:233&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">24185760</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehers KL, Long AE, van der Slik AR, et al. An increased frequency of NK cell receptor and HLA-C group 1 combinations in early-onset type 1 diabetes. Diabetologia. 2011;54:3062&#x2013;3070.</Citation><ArticleIdList><ArticleId IdType="pubmed">21909837</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen JH, Moore BE, Nakajima T, et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med. 2001;193:1159&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193323</ArticleId><ArticleId IdType="pubmed">11369787</ArticleId></ArticleIdList></Reference><Reference><Citation>Salim PH, Jobim M, Bredemeier M, et al. Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis. Clin Exp Immunol. 2010;160:325&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2883102</ArticleId><ArticleId IdType="pubmed">20082621</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong NC, Nasruruddin BA, Murad S, Ong KJ, Sukumaran KD. HLA antigens in Malay patients with systemic lupus erythematosus. Lupus. 1994;3:393&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">7841992</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart CA, Laugier-Anfossi F, V&#xe9;ly F, et al. Recognition of peptide&#x2013;MHC class I complexes by activating killer immunoglobulin like receptors. Proc Natl Acad Sci USA. 2005;102:13224&#x2013;13229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1201584</ArticleId><ArticleId IdType="pubmed">16141329</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellett F, Siannis F, Vukin I, Lee P, Urowitz MB, Gladman DD. KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue Antigens. 2007;69(Suppl. 1):106&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">17445179</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni S, Martin MP, Carrington M. The yin and yang of HLA and KIR in human disease. Semin Immunol. 2008;20:343&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3501819</ArticleId><ArticleId IdType="pubmed">18635379</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>